Sorry, there are no posts to display.
Please use the form below to search again.
Alternatively, you can browse the sitemap below.
Pages
- Home
- Careers
- General contact
- Cookie Policy
- Macrocycle discovery platform
- Disclaimer
- Inhaled Murepavadin
- Polyphor has been recognised as the winner of the “EU CAPITAL MARKET TRANSACTION OF THE YEAR” at the 2018 Lifestars Awards
- Privacy Rules
- News on home
- IPO Information
- About Spexis
- News
- Platforms
- Partnering
- News Ad-hoc
- News with Disclaimer
- News: Disclaimer
- Publications
- Conferences & events
- ColiFin®
- Home
- EBX-002
- EFPIA Disclosure Code
- Investor Relations (placeholder)
- Corporate Presentation
- Lonodelestat
- Balixafortide
Posts
- November 13, 2018: Polyphor wins the 2018 Lifestars Awards in the category “EU CAPITAL MARKET TRANSACTION OF THE YEAR”
- June 10–14, 2018: Bacterial Persistence and Antimicrobial Therapy, Ascona, Switzerland
- June 6-9, 2018: 41st European Cystic Fibrosis Conference (ECFS), Belgrad, Serbia
- June 1-5, 2018: ASCO, Chicago, US
- April 21 – 24, 2018: ECCMID, Madrid, Spain
- April, 16-17, 2018: 5th Annual Peptides Congress, London, UK
- March 21-23, 2018: European Breast Cancer Conference, Barcelona, Spain
- March 20-23, 2018: 38th ISICEM, Brussels, Belgium
- March 1-2, 2018: 5th International Congress on Infectious Diseases, Berlin, Germany
- February 16-18, 2018: 23rd International Symposium on Infections in Critically ill patients, Dublin, Ireland
- September 25-29, 2017: Discovery on Target, Boston, USA
- September 14-15, 2017: World Anti-Microbial Resistance Congress, Washington D.C., USA
- July 6-8, 2017: 2nd World Bronchiectasis Conference, Università degli Studi di Milano, Italy
- April 30-May 3, 2017: TIDES, San Diego, USA
- April 24-25, 2017: 4th Annual Peptides Congress, London, England
- March 20-22, 2017: Bio Europe Spring 2017, Barcelona, Spain